MyoKardia, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $5.3M | $11.4M | $42.0M | — | — |
| Operating income | −$287.8M | −$73.7M | −$58.7M | −$10.5M | −$23.2M | −$17.2M |
| Net income | −$276.2M | −$67.7M | −$57.0M | −$10.4M | −$22.9M | −$16.8M |
| Total assets | $456.1M | $407.3M | $282.8M | $201.3M | $116.6M | $46.9M |
| Total liabilities | $49.8M | $36.7M | $52.1M | $55.9M | $22.7M | $32.2M |
| Equity | $406.3M | $370.6M | $230.7M | $145.4M | $93.9M | −$36.9M |
| EPS (diluted) | — | — | — | $-0.32 | — | — |
| Shares out. | 40.3M | 35.9M | 31.4M | 27.0M | 27.1M | 3.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2019- Operating margin
- —
- Net margin
- —
- Return on equity
- −68.0%
- Return on assets
- −60.6%
- Return on capital (ROCE)
- −70.5%
- Liabilities / assets
- 10.9%
- Debt / equity
- 0.12×
- Book value / share
- $10.08
- Revenue growth (YoY)
- −100.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2019- Altman Z″ (distress)
- 6.31safe
- Accruals / assets
- −7.6%clean
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 warning● 3 good- Revenue declined year-over-year
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsNov 17, 2020
- Results of operationsNov 5, 2020
- Entered a material agreement · Other material eventOct 5, 2020
- Results of operationsAug 4, 2020
- Shareholder voteJun 24, 2020
- Entered a material agreement · Other material eventMay 14, 2020
- Other material eventMay 11, 2020
- Results of operationsMay 6, 2020
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BNov 27, 2020
- SC 13GNov 27, 2020
- S-8 POSNov 24, 2020
- S-8 POSNov 24, 2020
- S-8 POSNov 24, 2020
- S-8 POSNov 24, 2020
- S-8 POSNov 24, 2020
- POSASRNov 24, 2020
- 4FORM 4 SUBMISSIONNov 19, 2020
- 4FORM 4 SUBMISSIONNov 19, 2020
- 4FORM 4 SUBMISSIONNov 19, 2020
- 4FORM 4 SUBMISSIONNov 19, 2020
- 4FORM 4 SUBMISSIONNov 19, 2020
- 4FORM 4 SUBMISSIONNov 19, 2020
- 4FORM 4 SUBMISSIONNov 19, 2020
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.